{"id":12058,"date":"2025-06-04T13:29:43","date_gmt":"2025-06-04T11:29:43","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12058"},"modified":"2026-03-03T10:26:43","modified_gmt":"2026-03-03T09:26:43","slug":"3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca","status":"publish","type":"post","link":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","title":{"rendered":"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-1024x683.jpg\" alt=\"\" class=\"wp-image-27151\" style=\"width:528px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ou-voyez-vous-le-besoin-d-agir-le-plus-urgent-pour-la-place-pharmaceutique-suisse\"><strong>O\u00f9 voyez-vous le besoin d\u2019agir le plus urgent pour la place pharmaceutique suisse?<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\"><\/ol>\n\n\n\n<p>Selon moi, le besoin d\u2019agir le plus urgent concerne l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments et th\u00e9rapies innovants. Dans ce domaine, la Suisse ne doit pas manquer le coche. Pour conserver \u00e0 l\u2019avenir l\u2019un des meilleurs syst\u00e8mes de sant\u00e9 au monde, la pr\u00e9vention et le d\u00e9pistage pr\u00e9coce ainsi que les programmes de soins int\u00e9gr\u00e9s devraient en outre \u00eatre renforc\u00e9s. Pour y parvenir, les diff\u00e9rents acteurs du secteur de la sant\u00e9 doivent mieux collaborer.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-et-comment-souhaitez-vous-vous-engager-a-cet-egard-aupres-d-interpharma\"><strong>Et comment souhaitez-vous vous engager \u00e0 cet \u00e9gard aupr\u00e8s d\u2019Interpharma?<\/strong><\/h2>\n\n\n\n<p>Je tiens \u00e0 ce que ces th\u00e8mes soient reconnus et pris au s\u00e9rieux par l\u2019ensemble des parties concern\u00e9es. Ainsi, lors de notre <a href=\"https:\/\/www.srf.ch\/play\/tv\/tagesschau\/video\/tagesschau-vom-30-08-2024-hauptausgabe?urn=urn:srf:video:78c92637-78d7-459e-9f61-bfd599b1d16f&amp;startTime=1175\">conf\u00e9rence de presse<\/a> \u00e0 laquelle Interpharma a particip\u00e9, je veux continuer \u00e0 montrer aux responsables politiques et \u00e0 la soci\u00e9t\u00e9 \u00e0 quel point l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments innovants est important pour les patients et patientes, de m\u00eame que pour le syst\u00e8me de sant\u00e9 en Suisse. Je m\u2019engage \u00e9galement pour que l\u2019on reconnaisse les effets positifs \u00e0 long terme de la pr\u00e9vention et du d\u00e9pistage pr\u00e9coce pour un syst\u00e8me de sant\u00e9 durable et que l\u2019on ne se contente plus de d\u00e9battre des co\u00fbts \u00e0 court terme. Pour ce faire, nous avons par exemple men\u00e9 des discussions int\u00e9ressantes en pr\u00e9sence des acteurs nationaux et cantonaux au cours des \u00abTrendtage Gesundheit\u00bb de cette ann\u00e9e \u00e0 Lucerne lors de notre lunch-event.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-le-rapport-annuel-mettait-l-accent-sur-la-valeur-du-secteur-pharmaceutique-en-suisse-pour-les-patientes-et-patients-la-recherche-et-l-economie-quel-terme-vous-vient-spontanement-a-l-esprit-pour-chaque-domaine\"><strong>Le rapport annuel mettait l\u2019accent sur la valeur du secteur pharmaceutique en Suisse: pour les patientes et patients, la recherche et l\u2019\u00e9conomie. Quel terme vous vient spontan\u00e9ment \u00e0 l\u2019esprit pour chaque domaine?<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Pour les patientes et patients: <\/strong>acc\u00e8s \u00e9gal, \u00e9quitable et pr\u00e9coce aux th\u00e9rapies et la meilleure th\u00e9rapie possible dans les meilleurs d\u00e9lais<\/li>\n\n\n\n<li><strong style=\"color: initial;\">Pour la recherche: <\/strong><span style=\"color: initial;\">la Suisse est connue en tant que p\u00f4le d\u2019innovation, mais le secteur de la sant\u00e9 a encore du retard \u00e0 rattraper (acc\u00e8s, \u00e9tudes, num\u00e9risation)<\/span><\/li>\n\n\n\n<li><strong>Pour l\u2019\u00e9conomie: <\/strong>l\u2019industrie pharmaceutique est un employeur important; nous avons besoin des meilleurs talents et de bonnes relations avec l\u2019UE sont essentielles<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>O\u00f9 voyez-vous le besoin d\u2019agir le plus urgent pour la place pharmaceutique suisse? Selon moi, le besoin d\u2019agir le plus urgent concerne l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments et th\u00e9rapies innovants. Dans ce domaine, la Suisse ne doit pas manquer le coche. Pour conserver \u00e0 l\u2019avenir l\u2019un des meilleurs syst\u00e8mes de sant\u00e9 au monde, la pr\u00e9vention et [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3528,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[115,120,130],"class_list":["post-12058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-recherche-fr","tag-innovation-fr","tag-pharmastandort-2030-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma\" \/>\n<meta property=\"og:description\" content=\"O\u00f9 voyez-vous le besoin d\u2019agir le plus urgent pour la place pharmaceutique suisse? Selon moi, le besoin d\u2019agir le plus urgent concerne l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments et th\u00e9rapies innovants. Dans ce domaine, la Suisse ne doit pas manquer le coche. Pour conserver \u00e0 l\u2019avenir l\u2019un des meilleurs syst\u00e8mes de sant\u00e9 au monde, la pr\u00e9vention et [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-04T11:29:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:26:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1708\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\"},\"headline\":\"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca\",\"datePublished\":\"2025-06-04T11:29:43+00:00\",\"dateModified\":\"2026-03-03T09:26:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\"},\"wordCount\":395,\"image\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"keywords\":[\"Recherche\",\"Innovation\",\"Pharmastandort 2030\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\",\"name\":\"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"datePublished\":\"2025-06-04T11:29:43+00:00\",\"dateModified\":\"2026-03-03T09:26:43+00:00\",\"author\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\"},\"breadcrumb\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"contentUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg\",\"width\":2560,\"height\":1708},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#website\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iph-multisite.berta-bewegt.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/iph-multisite.berta-bewegt.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma","og_description":"O\u00f9 voyez-vous le besoin d\u2019agir le plus urgent pour la place pharmaceutique suisse? Selon moi, le besoin d\u2019agir le plus urgent concerne l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments et th\u00e9rapies innovants. Dans ce domaine, la Suisse ne doit pas manquer le coche. Pour conserver \u00e0 l\u2019avenir l\u2019un des meilleurs syst\u00e8mes de sant\u00e9 au monde, la pr\u00e9vention et [&hellip;]","og_url":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","og_site_name":"Interpharma","article_published_time":"2025-06-04T11:29:43+00:00","article_modified_time":"2026-03-03T09:26:43+00:00","og_image":[{"width":2560,"height":1708,"url":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#article","isPartOf":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/"},"author":{"name":"berta_admin","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3"},"headline":"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca","datePublished":"2025-06-04T11:29:43+00:00","dateModified":"2026-03-03T09:26:43+00:00","mainEntityOfPage":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/"},"wordCount":395,"image":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","keywords":["Recherche","Innovation","Pharmastandort 2030"],"inLanguage":"fr-FR","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","url":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/","name":"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca - Interpharma","isPartOf":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage"},"image":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","datePublished":"2025-06-04T11:29:43+00:00","dateModified":"2026-03-03T09:26:43+00:00","author":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3"},"breadcrumb":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#primaryimage","url":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","contentUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2025\/06\/AZ_Florian-Saur_1-scaled.jpg","width":2560,"height":1708},{"@type":"BreadcrumbList","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"3 questions \u00e0 nos nouveaux membres du conseil d\u2019administration: Florian Saur, Country General Manager Switzerland, AstraZeneca"}]},{"@type":"WebSite","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#website","url":"https:\/\/iph-multisite.berta-bewegt.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iph-multisite.berta-bewegt.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/iph-multisite.berta-bewegt.ch"]}]}},"_links":{"self":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/12058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/comments?post=12058"}],"version-history":[{"count":1,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/12058\/revisions"}],"predecessor-version":[{"id":12059,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/12058\/revisions\/12059"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/media\/3528"}],"wp:attachment":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/media?parent=12058"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/tags?post=12058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}